Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR vs OxyPR in pain with constipation
NCT01438567Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Sep 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone + naloxone in pain (2 arms), sponsored by Mundipharma. Primary endpoint: Bowel Function Index at 6 months. Started Sep 2011; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
pain
Beyond the preview
Go deeper on NCT01438567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438567.